United Therapeutics enters $477.6M ASR to complete $2B buyback authorization

UNITED THERAPEUTICS Corp

Entered ASR with Citibank to repurchase ~$477.6M stock; upfront payment ~Sept 10, 2026.
Initial delivery ~719,376 shares (75% of anticipated total based on 9/8/26 close); final settlement Q4 2026.
Prior repurchases: $1.5B ASR in March 2026 and $22.4M open-market in Q3 2026.
CEO states $4B returned to shareholders in ~2.5 years; ~42.9M shares outstanding as of Sept 4, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.